Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice
Aline Boveto Santamarina, Milena Carvalho‐Silva, Lara M. Gomes, et al.
The Journal of Nutritional Biochemistry (2015) Vol. 26, Iss. 11, pp. 1348-1356
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The role of the gut microbiota in NAFLD
Christopher Leung, Leni R. Rivera, John B. Furness, et al.
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 7, pp. 412-425
Closed Access | Times Cited: 837
Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review
Guo‐Yi Tang, Xiao Meng, Ren‐You Gan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6196-6196
Open Access | Times Cited: 300
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 56-56
Open Access | Times Cited: 170
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Lara P. Fernández, Marta Gómez de Cedrón, Ana Ramı́rez de Molina
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 159
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation
Gaolong Zuo, Meiyan Chen, Yingpeng Zuo, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 16
Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function
Hossein Rafiei, Kosar Omidian, Brian Bandy
Nutrients (2019) Vol. 11, Iss. 3, pp. 541-541
Open Access | Times Cited: 100
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
Guo‐Yi Tang, Yu Xu, Cheng Zhang, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1076-1076
Open Access | Times Cited: 83
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 22-43
Open Access | Times Cited: 69
Effects of processing technology on tea quality analyzed using high-resolution mass spectrometry-based metabolomics
Jie Wang, Zhen Li
Food Chemistry (2024) Vol. 443, pp. 138548-138548
Closed Access | Times Cited: 7
Microbiota, Obesity and NAFLD
Louis Ho Shing Lau, Sunny H. Wong
Advances in experimental medicine and biology (2018), pp. 111-125
Closed Access | Times Cited: 78
Chronic Inflammatory Diseases and Green Tea Polyphenols
Helieh S. Oz
Nutrients (2017) Vol. 9, Iss. 6, pp. 561-561
Open Access | Times Cited: 74
Quercetin and Epigallocatechin Gallate in the Prevention and Treatment of Obesity: From Molecular to Clinical Studies
Catalina Carrasco‐Pozo, Marı́a José Cires, Martín Gotteland
Journal of Medicinal Food (2019) Vol. 22, Iss. 8, pp. 753-770
Closed Access | Times Cited: 74
Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
Laura Antonucci, Cristiana Porcu, Gino Iannucci, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1137-1137
Open Access | Times Cited: 71
Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids
Masoumeh Akhlaghi
Phytotherapy Research (2016) Vol. 30, Iss. 10, pp. 1559-1571
Closed Access | Times Cited: 69
Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease
Jie Zhou, Chi‐Tang Ho, Piaopiao Long, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 19, pp. 5306-5317
Closed Access | Times Cited: 68
Potential Biological Effects of (‐)‐Epigallocatechin‐3‐gallate on the Treatment of Nonalcoholic Fatty Liver Disease
Cheng Chen, Qian Liu, Lin Liu, et al.
Molecular Nutrition & Food Research (2017) Vol. 62, Iss. 1
Open Access | Times Cited: 65
Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases
Can Cheng, Zhenzhen Li, Xu Zhao, et al.
European Journal of Pharmacology (2020) Vol. 870, pp. 172922-172922
Closed Access | Times Cited: 61
Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review
Omar Abunofal, Chandra Mohan
Medicines (2022) Vol. 9, Iss. 3, pp. 20-20
Open Access | Times Cited: 27
Green Tea Catechins as Therapeutic Antioxidants for Glaucoma Treatment
Tsz Kin Ng, Kai On Chu, Chi Chiu Wang, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1320-1320
Open Access | Times Cited: 19
The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates
Ruike Yan, Yanli Cao
Biomedicines (2025) Vol. 13, Iss. 1, pp. 206-206
Open Access
Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver
Fang Zhou, Shengyuan Deng, Yong Luo, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1101-1101
Open Access
Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
Rongying Ou, Jia Liu, Mingfen Lv, et al.
Endocrine (2017) Vol. 57, Iss. 1, pp. 72-82
Closed Access | Times Cited: 60
Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity
Qiao Zhang, Hang Yuan, Cong Zhang, et al.
Diabetes Research and Clinical Practice (2018) Vol. 142, pp. 363-373
Closed Access | Times Cited: 55
Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
Sainan Li, Yujing Xia, Kan Chen, et al.
Drug Design Development and Therapy (2016), pp. 631-631
Open Access | Times Cited: 54
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization
Yong Du, Laura Paglicawan, Sanam Soomro, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 599-599
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top